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Abstract
Background: MALDI-TOF MS recently emerged as a valuable identification tool for bacteria and yeasts and revolutionized
the daily clinical laboratory routine. But it has not been established for routine mould identification. This study aimed to
validate a standardized procedure for MALDI-TOF MS-based mould identification in clinical laboratory.
Materials and Methods: First, pre-extraction and extraction procedures were optimized. With this standardized procedure,
a 143 mould strains reference spectra library was built. Then, the mould isolates cultured from sequential clinical samples
were prospectively subjected to this MALDI-TOF MS based-identification assay. MALDI-TOF MS-based identification was
considered correct if it was concordant with the phenotypic identification; otherwise, the gold standard was DNA sequence
comparison-based identification.
Results: The optimized procedure comprised a culture on sabouraud-gentamicin-chloramphenicol agar followed by a
chemical extraction of the fungal colonies with formic acid and acetonitril. The identification was done using a reference
database built with references from at least four culture replicates. For five months, 197 clinical isolates were analyzed; 20
were excluded because they were not identified at the species level. MALDI-TOF MS-based approach correctly identified
87% (154/177) of the isolates analyzed in a routine clinical laboratory activity. It failed in 12% (21/177), whose species were
not represented in the reference library. MALDI-TOF MS-based identification was correct in 154 out of the remaining 156
isolates. One Beauveria bassiana was not identified and one Rhizopus oryzae was misidentified as Mucor circinelloides.
Conclusions: This work’s seminal finding is that a standardized procedure can also be used for MALDI-TOF MS-based
identification of a wide array of clinically relevant mould species. It thus makes it possible to identify moulds in the routine
clinical laboratory setting and opens new avenues for the development of an integrated MALDI-TOF MS-based solution for
the identification of any clinically relevant microorganism.
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Introduction
Fast and reliable identification of moulds would help manage
the growing number of invasive mould infections, a leading cause
of morbidity and lethality in immunocompromised patients [1].
Currently, mould identification relies on the macroscopic and
microscopic observation of colonies grown on mycological media.
Adequate phenotypic identification of moulds requires highly
skilled mycologists, who are found in a few reference laboratories.
Moreover, some species phenotypically indistinguishable have
been described based on DNA sequence analysis of rRNA or other
protein-coding genes. Yet, even DNA sequence-based identifica-
tion of moulds has several limitations. The DNA extraction yield
may be relatively low because mould cells are hard to lyse. PCR
amplification may fail due to the presence of PCR inhibitors in
mould cultures. Moreover, although it may technically succeed,
the molecular identification of moulds would require at least 5 to 7
days in the routine clinical laboratory setting. This delay negatively
impacts the patients’ prognosis [2]. Finally, only some clinical
laboratories routinely use a molecular approach for microorgan-
ism identification [3]. In 2007, only 17% of the US clinical
laboratories performed molecular analysis [4]. Therefore the
identification of moulds remains problematic and misidentifica-
tions likely occur in the routine setting [5].
A novel microorganism identification method has emerged in
bacteriology that is based on MALDI-TOF mass spectrum (MS)
analysis. This MALDI-TOF MS-based identification technique
analyzes the protein content from treated or intact cells of
microorganisms under the form of a spectrum that is considered as
a protein fingerprint specific of a micro-organism. An unknown
microorganism is identified by comparing its spectrum with the
spectra in the reference library [6]. MALDI-TOF MS-based
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throughput for most bacteria. Numerous bacteriologists found
that its identification accuracy outperformed that of conventional
methods in the routine clinical laboratory setting [7]. A few
preliminary studies aimed to identify moulds using MALDI-TOF
MS [8]. However, each used only specific mould genera and
culture conditions. Different extraction methods, types of matrix,
and instruments were also used. This heterogeneity is particularly
detrimental because mass spectra are influenced by culture
conditions, extraction procedures, the type of matrix, and the
spectrometer used [9]. Our study therefore sought to elaborate a
standardized procedure suitable for the MALDI-TOF MS-based
identification of clinically relevant moulds in the routine
laboratory setting. In the first step, the operating procedures for
MALDI-TOF MS-based identification were optimized and
validated on a large panel of clinically relevant moulds. In the
second step, we evaluated the performances of this MALDI-TOF
MS-based approach for the identification of mould clinical isolates
prospectively collected from the routine activity of the Marseille
teaching hospital laboratory. Moulds were considered regardless of
their phylogeny and relation to any specific clinical situation.
Materials and Methods
Fungal strains
Three panels of mould strains were used in this study. The panel
P1 included 8 strains. The panel P2 included the 8 strains of the
panel P1 and 11 other strains. The panel P3 (146 strains) included
the strains of the panels P1 and P2 and 127 other strains. Panels 1
and 2 (Table S1) were used to optimize spectra acquisition. Panel 3
was used to validate the optimized process with clinical isolates. Of
the 146 strains, 85 and 24 were graciously provided by respectively
the BCCM/IHEM and the Pasteur Institute; they had been
identified by macroscopic and microscopic examination by skilled
mycologists and by ITS gene sequencing [10]. Beta-tubuline
sequencing [11] was performed when required. The 37 remaining
strains were recovered from clinical or environmental samples
received at our lab (Table S1).
Phenotypic and genotypic identifications
The clinical and environmental strains were first identified by
skilled mycologists according to their phenotypic (macroscopic and
microscopic) features following the keys of the Atlas of clinical
fungi [12]. Identification was then confirmed by DNA sequence-
based identification using both ITS1-5.8S-ITS2 and the D1-D2
variable region of the 28S unit of the rRNA gene as described by
deHoog et al [13]. DNA extraction was performed using the
QIAmp DNA kit (QIAGEN, France) and identified reaction
sequences were run with a 3130 Genetic Analyzer (Applied
Biosystem, Inc., Courtaboeuf, France). Resulting sequences were
compared using the Medical fungi pairwise sequence alignment
tool (http://www.cbs.knaw.nl/Medical/BioloMICSSequences.
aspx).
Fungal material extraction
The fungi were extracted using formic acid (FA) as follows.
Fungal culture samples were mixed with 300 mL of sterile water
(Water HPLC, Prolabo BDH, Fontenay-sous-Bois, France) and
900 mL of anhydrous ethyl alcohol (Carlo Erba SDS, Val de Reuil,
France) in a sterile 1.5 ml tube. After 10 min centrifugation at
13,000 g, the pellet was incubated 5 min in 10 mL of 70% formic
acid (Sigma-Aldrich, Lyon, France). Then 10 mL of 100%
acetonitrile (Prolabo BDH) was added for 10 min of incubation
before centrifugation (13,000 g, 2 min) and the supernatant was
removed. Five pre-extraction operating procedures were tested.
A. Fungi were cultivated on Sabouraud gentamicin-chloram-
phenicol agar plates (AES, France) and incubated 72 h at
27uC. The samples, i.e. fungal hyphae and spores, were
harvested by gently scraping the fungal colonies with a sterile
plastic device and then subjected to FA extraction as
described above.
B. The fungi were cultured for 24 h at 27uC on Sabouraud
broth (BioMerieux, France). Fungal material was collected
after 10 min centrifugation at 13,000 g. Then the pellet was
washed three times with 1 ml of sterile water and suspended
with 300 mL of HPLC sterile water and 900 mL of anhydrous
ethyl alcohol in a sterile 1.5 ml tube subjected to FA
extraction as described above.
C. This procedure was identical to procedure A except that the
hydro-alcoholic suspension of fungal material was heated 1 h
at 95uC before extraction as described above.
D. This procedure was identical to A except that the hydro-
alcoholic suspension of fungal material was mechanically
lysed by 3 cycles of micro-beads (Glass beads, acid-washed
G4649 -#106 mm, Sigma-Aldrich, Saint Quentin Fallavier,
France) beating (60 seconds at power 6.5) with a FastPrep
TM-
24 Instrument (MP Biomedicals, France) before extraction as
described above.
E. This procedure was identical to D except that the hydro-
alcoholic suspension of fungal material was heated 1 h at
95uC before mechanical lysis as described above.
Mass spectra acquisition and MALDI-TOF MS-based
identification
A drop of 1 mL of supernatant was deposited on a spot of a
polished steel target (MTP384 polished steel target, Bruker
Daltonics GmbH, Bremen, Germany) and air-dried. Each spot
was then covered with 1 mL of the matrix solution. The matrix
solution was a daily-prepared saturated solution of a-cyano-4-
hydroxycinnamic acid (HCCA) in 50% acetonitrile (and 2.5%
trifluoroacetic acid (TFA) (Sigma-Aldrich, Lyon, France). The
spectra were acquired after 650 shots in linear mode with an
Autoflex speed
TM I, Autoflex speed
TM II, or UltrafleXtreme
TM
instrument (BrukerDaltonics, Germany) in the ion-positive mode
with a 337 nm nitrogen laser. The following adjustments were
used: delay: 170 ns; ion source1 voltage: 20 kV; ion source2
voltage: 18.5 kV; mass range: 3–20 kDa. The data were
automatically acquired by the AutoXecute of the FlexControl
v2.4 software and exported into MaldiBiotyper v2.1 software.
Only peaks with a signal/noise ratio $10 were considered.
Reference spectra (MSP) were created by combining the results
of 10 raw spectra per fungal isolate using the ‘‘MSP creation’’
function of the MaldiBiotyper software. LogScore values (LS) were
obtained by comparing unknown sample spectra with a reference
library using the ‘‘Start identification’’ function of the MaldiBio-
typer software. LS-based identification results were considered
correct when they agreed with those of phenotypic/genotypic
identification.
Consecutive clinical isolates, cultured on Sabouraud gentami-
cin-chloramphenicol agar plates at 27uC for 72 h, were prospec-
tively collected from the routine activity of the medical mycology
laboratory at the teaching hospital of Marseille. They were
identified using phenotypic criteria as described above. In parallel,
samples were prepared according to procedure A, as described
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MALDI-TOF MS using the largest library, which included the
reference spectra of 146 filamentous fungi strains. The MS-
comparison was based on the best-match LS values, as described
in the reproducibility analysis paragraph.
The MS identification results of the clinical isolates were
interpreted as follows:
– If less than 3 out of the 4 spots issued from an isolate matched
MSPs of the same species, the result of the MALDI-TOF MS-
based identification for the isolate were considered non
interpretable. This intra-spot discordance may be caused by
a possible technical error. The clinical isolate was cultured,
extracted, and submitted to MS identification again.
– If at least 3 out of the 4 spots issued from a clinical isolate
matched MSPsofthe same species,the MALDI-TOFMS-based
identifications were considered concordant and interpretable. If
the MALDI-TOF MS-based identification matched the pheno-
typic one, the clinical isolate was considered correctly identified
by MALDI-TOF MS. Otherwise the isolates were further
identified by DNA sequence comparison as described above. If
the identification by DNA sequence comparison gave the same
result as the MALDI-TOF MS-based identification, the clinical
isolate was considered correctly identified by MALDI-TOF MS,
regardless of the phenotypic identification. If the DNA sequence
comparison identification did not match the MALDI-TOF MS-
based identification, the isolate was considered misidentified by
MALDI-TOF MS.
Comparison of extraction procedures
Five MSPs libraries (one for each pre-extraction operating
procedure) were built. Each library contained eight MSPs, one for
each of the eight first panel’s isolates (P1). Each of these MSPs was
Figure 1. MALDI TOF MS spectra obtained with the 5 extraction procedures. (A) Gel view of the spectra of the Aspergillus fumigatus
AFUM001strain obtained with the different extraction procedures. (B) List view of the spectra of the AFUM001obtained with the different extraction
procedures. These procedures are detailed in the Material and Method section. The peaks obtained with procedure B, C and E were fewer and of
lower intensity than those obtained with procedures A.
doi:10.1371/journal.pone.0028425.g001
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composing an MSP was submitted to MS identification, and the
best-match LS values were calculated using MaldiBiotyper. We
then compared the number of peaks composing the spectra and
the best-match LS values obtained with each strain of the panel
with the five procedures. The C and E procedures were discarded
at this step because they produced poor quality spectra.
To assess the technical reproducibility of the spectra obtained
by procedures A, B, and D, we built three larger libraries, DB1-A,
DB1-B, and DB1-D, which each included 19 MSPs. The MSPs
were derived from 10 raw spectra obtained from a single culture of
each strain included in the second panel (P2). Then, for each
procedure, we compared each 190 raw spectrum to the 19 MSPs
in the corresponding library and calculated the resulting best-
match LS values. To test biological reproducibility, the 19 strains
of panel P2 were further subcultured and extracted according to
A, B, or D procedure. Then four spots of each extracted samples
were compared to the MSPs in the corresponding library and LS
values were analyzed.
Statistical analysis
All statistical analyses were performed using two-sided tests and
ap ,0.05 significance level with the MASS package of the R
software (http://www.r-project.org). The results of each extraction
protocol were compared using the non-parametric rank sum
Kruskal-Wallis test. In the case of a significant difference with the
Kruskal-Wallis test, a post-hoc analysis was conducted using
pairwise matched Wilcoxon tests with Holm’s adjustment for
multiple comparisons. The McNemar test without continuity
correction was used for the pairwise comparisons of correct
identification proportions.
Reference spectra (MSP) library validation
A large library of reference spectra was constructed using
extraction procedure A. This library included four MSPs (each of
them derived from 10 raw spectra of four culture replicates) of 146
strains included in the P3 panel (Table S1). To assess the validity of
this library, the 146 strains were sub-cultured again and submitted
to extraction following pre-extraction procedure A. Four spots of
each extracted sample were submitted to MS identification using
this 146-reference spectra library, and the LS values of each spot
were recorded.
Results
Comparison of extraction procedures
The results with the 8-strains panel P1 indicated that both the
number of peaks and the best-match LS values differed
significantly with the procedures used (Kruskal Wallis tests for
global heterogeneity: p,10
215 and p,10
211 respectively). The
Figure 2. Comparison of the quality of spectra obtained from
the5differentextractionprocedures.(A)Box-and-whiskerdiagrams
of the number of peaks per spectra of the 5 procedures. (B) Box-and-
whisker diagrams of the best-match LS value of the 5 procedures. The
bottom and top of the box are the lower and upper quartiles,
respectively; the band near the middle of the box represents the
median; and the ends of the whiskers represent the lowest datum still
within 1.5 interquartile range (IQR) of the lower quartile and the highest
datum still within 1.5 IQR of the upper quartile. Asterisks indicate which
pairs of procedures were statistically different (Wilcoxon tests, p,10
23).
Procedures A, B, and D displayed significantly more peaks (p,10
24) and
higher best-match LS values (p,10
23) than procedures C and E. No
statistically significantly difference was found between procedure C and
E on the one han and between procedures A, B, D on the other hand.
doi:10.1371/journal.pone.0028425.g002
Figure 3. Comparison of the technical and biological repro-
ducibility between the procedure A, B and D. (A) Box-and-whisker
diagram of the best-match LS value obtained in the technical
reproducibility test. (B) Box-and-whisker diagram of the best-match LS
value obtained in the biological reproducibility test. The bottom and
top of the box are the lower and upper quartiles, respectively; the dark
band is the median; and the ends of the whiskers represent the lowest
datum included in the 1.5 interquartile range (IQR) of the lower quartile
and the highest datum included in the 1.5 IQR of the upper quartile).
Asterisks indicate which pairs of procedures were statistically different
(Wilcoxon tests, p,10
23). The pairwise matched Wilcoxon tests with
Holm’s adjustment for multiple comparisons indicated that the
technical reproducibility was significantly better with procedure A than
with procedures B and D (p,10
216 and p,10
212 respectively).
Furthermore, the biological reproducibility with procedure B was
significantly poorer than with procedure A (p,10
29).
doi:10.1371/journal.pone.0028425.g003
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and E, and, on the other hand, procedures A, B and D were not
statistically significantly different (p.0.05). Procedures A, B, and
D displayed significantly more peaks (p,10
24; Figure 1) and
higher best-match LS values (p,10
23, Figure 2) than procedures
C and E. Using the same statistical analysis with the 19-strains
panel P2, we found that the best-match LS values for both
technical and biological reproducibility assays differed between the
procedures A, B and D (global heterogeneity tests, p,10
215 and
p,10
211, respectively). Post-hoc analysis indicated that the
technical reproducibility was significantly better with procedure
A than with procedures B and D (p,10
216 and p,10
212
respectively). Furthermore, procedure B was rejected because its
biological reproducibility was significantly poorer than procedure
A( p ,10
29, Figure 3). Finally, procedure D was rejected because it
was more laborious than A. The ultimate library and further
experiments were thus done following procedure A.
MSP library validation
The ultimate 146-strain library was first tested by comparing the
raw MSPs of a subculture of each strain used to build the library
with the MSPs in the library. All 584 spots tested (4 per strain) led
to correct identification at the species level with high best-match
LS (mean LS=2.394+/20.198). In contrast, for each spot, the
maximum best-match LS score value corresponding to a
misidentification (i.e. a species different from the one correspond-
ing to the sample) was much lower (mean=1.484+/20.3104).
Therefore, the distributions of the best-match LS values for the
spectra resulting either in a correct identification or a misidenti-
fication did almost not overlap (Figure 4).
Prospective MALDI-TOF MS-based identification of
clinical isolates
From the 197 clinical isolates collected between July and
November 2010, 177 (90%) could be correctly identified at the
species level (i.e. because phenotypic and MALDI-TOF MS-based
identifications were concordant, or by DNA sequence comparison-
based identification) (Table 1). Twenty isolates were excluded from
the evaluation because they were not identified to the species by
DNA sequence comparison-based identification. The 177 identified
isolates belonged to 33 species (Table 1). Twenty one isolates
belonged to 16 species that were not represented by an MSP in our
ultimate library and thus could not be identified. As expected, results
of MS identification of these 21 isolates yielded low best-match LS
value (mean=1.36960.176). Noticeably, intra-spot identification
wasdiscordantineachofthese21 isolatesandno MALDI-TOFMS-
based identification could be obtained. These results are important
because they demonstrate that isolates whose species is not present in
the reference library were not misidentified. The 156 remaining
clinicalisolateshadatleastonecorrespondingMSPfromanisolateof
the same species in the 146-strain library and could thus be correctly
identified by our MALDI-TOF MS-based identification assay.
For 150 (96.15%) of these 156 isolates, the MALDI-TOF MS-
based species identification was correct. The intra-spot concor-
dance was 100% for 141 of the 156 isolates i.e. the 4 spots yielded
the same identification at the species level. Their corresponding
best-match LS values were high. For the 9 remaining isolates, only
three spots were concordant, whereas the fourth gave a discordant
identification. As plotted in Figure 5, the mean best-match LS
values were higher for the concordant spots (2.14160.259) than
for the discordant ones (1.34160.189).
One isolate was misidentified as Mucor circinelloides by MALDI-
TOF MS because the spectra of three concordant spots matched
with Mucor circinelloides (mean best-match LS=1.74360.165), but
the phenotypic/genotypic identification was Rhizopus oryzae.
In five isolates no MALDI-TOF MS-based identification was
obtained because of intra-spot discordant results; each of the four
spots matched with four distinct species’ MSPs with low best-match
LS values (mean=1.224+/20.195). A new subculture of these five
isolates was subjected to a new extraction step, which markedly
enhanced the spectra quality in four of these five isolates.
Identification at the species level was correct for three isolates with
four concordant spots with high best-match LS values (Table 2).
Identification at the genus level was correct for one Penicillium
chrysogenum isolate with three concordant spots (Table 2). The fifth
isolate, identified as Beauveria bassiana by DNA sequence-based
identification, could not be identified by MALDI-TOF MS because
a new assay did not improve the previous results (the four spots were
discordant with low best-match LS values) (Table 2).
In summary, from the clinical point of view, this MALDI-TOF
MS-based approach was able to correctly identify 87% (154/177) of
Figure 4. Distribution of the best-match LS values recorded during the mass spectra library validation test. The figure shows the best-
match LS values for each of the 4 spots issued from a subculture of the 146 strains included in the library. The dark line represents the best-match LS
values of the correct identification results whereas the gray line shows the best-match LS values of the misidentification results. The distributions of
the best-match LS values for the spectra resulting either in a correct identification or a misidentification did almost not overlap.
doi:10.1371/journal.pone.0028425.g004
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in 12% (21/177), whose species were not represented in the
reference library. When focusing on the 156 clinical isolates for
which at least one MSP of the same species was present in the
library, at least three concordant spots were obtained for 151
(96.8%) isolates, leading to an initial correct MALDI-TOF MS-
based identification in 150 (96.15%) of them. When taking into
account the results of a replicate analysis of all isolates that initially
yielded less than three concordant spots, which is indicative of a
possible technical error, the MALDI-TOF MS-based identification
resulted in 154 (98.7%) correct identifications at the species level.
Discussion
This is the first demonstration that a standardized MALDI-
TOF procedure is capable to identify a large array of distinct
mould species that are routinely isolated in the clinical laboratory
setting. In this setting, MALDI-TOF MS-based identification has
already revolutionized the identification of bacteria and yeasts [7].
A growing number of clinical laboratories are now equipped with
MALDI-TOF MS-based solutions for the MALDI-TOF MS-
based identification of micro-organisms. Yet the lack of standard-
ized procedure applicable to the routine identification of moulds
isolated in the clinical laboratory routine remained the major gap
in commercialized solutions to date. It was thus critical to develop
a similar solution for the identification of moulds.
Data on MALDI-TOF MS-based identification of moulds are
scarce in the literature. The limited number of studies have
focused on specific genera or phylogenetic complexes such as
Aspergillus, Penicillium, Trichophyton, Fusarium, Verticillium, Trichoderma,
and Scedosporium [14,15,16,17,18,19,20,21], and each of them used
heterogeneous fungal cultures or extraction procedures. For
Table 1. Results of the polyphasic identification of 177 clinical mould isolates.
Species nb of isolates
nb of concordances
micro/spectro
nb of confirmations
by molecular biology
nb of strains of the
species in the spectral bank
Aspergillus fumigatus 86 84 2 11
Aspergillus niger 12 11 1 4
Alternaria tenuissima/alternata 10 4 6 8
Aspergillus flavus 99 0 5
Aspergillus terreus 99 0 7
Penicillium chrysogenum 82 6 6
Scedosporium apiospermum 72 5 6
Penicillium glabrum 40 4 0
Rhizopus oryzae 30 3 4
Aspergillus alliaceus 20 2 0
Aspergillus nidulans 22 0 5
Fusarium oxysporum 21 1 5
Geotrichum geomyces 20 2 0
Penicillium spirulosum 20 2 1
Aspergillus clavatus 10 1 0
Aspergillus melleus 10 1 0
Aspergillus oryzae 10 1 0
Aspergillus sydowi 10 1 1
Beauveria bassiana 10 1 6
Chaetomium globosum 10 1 1
Fomitopsis ostreiformis 10 1 0
Geosmithia pallida 10 1 0
Hamigera avallanea 10 1 0
Hypocrea jecorina 10 1 0
Nectria mauriticaula 10 1 0
Penicillium citrinum 10 1 0
Penicillium funiculosum 10 1 0
Penicillium oxalicum 10 1 0
Penicillium roqueforti 10 1 1
Penicillium spinophilum 10 1 0
Paecilomyces variotii 10 1 4
Trichoderma atroviride 10 1 0
Trichoderma viride 11 0 2
Total 177 125 52
(Nb, number; micro, phenotypic identification; spectro, MALDI TOF MS-based identification).
doi:10.1371/journal.pone.0028425.t001
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20 days for Hettick [14,19], and extraction was performed from
spores [9,15], hyphae [18,19], or both spores and hyphae
[16,17,20,22]. A wide array of extraction procedures have been
used, including heating, sonication, bead-beating, or chemical
lysis. DHB and a-HCCA matrix were mostly used but Welham
et al. and Valentine et al. used a hydroxyphenylphenylbenzoic
acid- and a ferrulic acid-based matrix, respectively [9,22]. Here we
selected an optimized procedure suited to the identification of the
main relevant mould species in the clinical laboratory setting.
Indeed, when challenging the subcultures of the strains included in
our library, we obtained high best-match LS values, comparable to
those obtained for bacteria or yeast identification [7].
As explained by Giebel et al., an ideal mass spectral
identification system for moulds needs to be simple, with a high
turnaround time, fast in handling, robust with respect to variations
and variability in culture conditions, reproducible to allow
identifications at different locations, applicable to the majority of
clinically relevant microorganisms, and economical to allow
identifications at competitive costs [23]. In our study, the first
step resulted in an optimized extraction procedure adapted to the
laboratory routine. We used Sabouraud-chloramphenicol-genta-
micin agar, which is the most widely used fungal isolation medium
in clinical laboratories. Few studies dealing with hyaline molds
producing numerous conidia (Aspergillus sp. [22,24], Penicillium sp.
[15], Rhizopus sp [22]., Trichoderma sp. [22] and Phanerochaete sp. [22])
lead to reproducible mass fingerprints by intact fungal cells
analysis. However we failed to obtain interpretable spectra from
dematious, poorly- or non-sporulating molds. Thus we used a
chemical extraction step to achieve a good quality of spectra from
any molds. In keeping with Coulibaly et al. [21], formic acid-based
extraction was chosen because it was faster, less toxic, and resulted
in an identification quality similar to that of trifluoroacetic acid-
based extraction.
An a-HCCA-based matrix was selected because it is extensively
used for bacterial and yeast identification and because it had
succeeded in identifying Aspergillus, Fusarium, and Pseudallescheria/
Scedosporium isolates [7,17,18,20,25]. Except for those including a
Figure 5. Distribution of the best-match LS values issued from
the identification of the clinical isolates. This figure shows the
distribution of the best-match LS values for each of the 4 spots issued
from identification of the 156 clinical isolates. The dark line indicates the
best-match LS values of the concordant spots whereas the gray line
shows the best-match LS values of the discordant ones. Concordant and
discordant spots best-match LS value distributions were almost distinct.
doi:10.1371/journal.pone.0028425.g005
Table 2. Best-match LS values of 5 isolates with intra-spot discordant results at the first identification assay.
First MS Identification Second MS Identification
Isolate Result Score Result Score
A. fumigatus P. exophialae 1. 301 A. fumigatus 2.009
A. fumigatus 1. 460 A. fumigatus 2.114
A. niger 1. 354 A. fumigatus 1.874
A. strictum 1. 456 A. fumigatus 1.883
S. apiospermum S. inflatum 1. 063 S. apiospermum 2.067
F. oxysporum 0. 931 S. apiospermum 2.014
A. hollandicus 0. 771 S. apiospermum 1.995
A. nidulans 0. 994 S. apiospermum 1.903
P. chrysogenum Alternaria sp. 0. 998 P. roqueforti 1.533
A. terreus 1. 169 P. roqueforti 1.641
S. apiospermum 1. 117 P. roqueforti 1.476
F. verticillioides 1. 058 P. aurantiogriseum 1.636
B. bassiana B. bassiana 1. 280 M. circinelloides 1.761
P. spirulosum 1.308 C. sphaerospermum 1.760
Oedocephalum sp 1.366 M. circinelloides 1.856
P. chermesinum 1.226 B. bassiana 1.805
A. niger F. oxysporum 1. 382 A. niger 2.021
A. nidulans 1. 389 A. niger 2.174
P. chrysogenum 1. 472 A. niger 1.960
F. oxysporum 1. 381 A. niger 1.992
(MS: mass spectrometry).
doi:10.1371/journal.pone.0028425.t002
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spectra profiles with .40 peaks. This clearly exceeds the 17-peak
threshold ensuring the species specificity of a spectrum [16].
Finally procedure A, based on formic acid extraction, was selected
because it was both the most reproducible and the easiest to
perform in a routine setting.
The final evaluation of clinical isolates collected from the
routine activity of our laboratory fairly succeeded. Testing the
validity of our entire process in identifying clinical isolates in
parallel with conventional methods, we identified 154 (87%) out of
177 isolates. These findings are very encouraging especially when
considering that the reference library used was 20 times smaller
than bacteria libraries. Our tentative library, which included only
references for 146 strains belonging to only 63 species and 33
different genera, allowed the identification at the species level of
87% of the isolates identified in the routine activity of a clinical
laboratory for 5 months. Seng et al. identified 84% of the bacterial
isolates in clinical bacteriology laboratory routine with a 2881
reference library [7]. Since 2009 the MALDI-TOF MS based
identification of bacteria increased with the number of reference
spectra in the libraries. To date, our findings constitute a proof of
concept that moulds identification can be adapted to the routine
clinical laboratory and it is likely that MALDI-TOF MS based
identification moulds will also benefit from strengthening reference
libraries.
This novel standardized MALDI-TOF MS-based mould
identification assay allowing the timely and accurate identification
of clinically relevant moulds at the species level in the routine
microbiology laboratory setting is likely to dramatically alter the
management of fungal infections. Our findings demonstrate that
MALDI-TOF MS identification is efficient for the rapid and
routine identification of mould isolates in the clinical laboratory
and, in line with the current practices of bacteria identification in
the growing number of microbiology laboratories equipped with
bench-top MALDI-TOF instruments, it could be used, ahead of
morphological identification, as a first-line method for mould
identification. Additionally, this MALDI-TOF MS identification
process will have a great impact on several other research areas
that would benefit from a high throughput and accurate mould
identification assay. Indeed, moulds are of growing interest in
human health, food safety management, and the control of
phytopathogenic fungi. Some species (i.e. in Penicillium or Aspergillus
genera) have been associated with allergic diseases [26]. In
contrast, Ege et al. recently pointed to the significant protection
against childhood asthma associated with exposure to farm
microbiota, and especially fungal taxa [27]. Furthermore, the
human-health consequences of mycotoxins produced by species of
Aspergillus, Penicillium, Claviceps, Fusarium, and Alternaria are of
concern, as is the burden of phytopathogenic fungi on farming
[28]. With its potential to identify a wide array of microorganism
species at the strain level within minutes, this unique microorgan-
ism identification approach will indubitably increase our under-
standing of the complex human health and environmental
microbiota interactions in the very near future.
MALDI-TOF MS recently became one of the routine
microorganism identification tools in the clinical laboratory. This
work’s seminal finding is that, akin to bacteria and yeasts, a
standardized procedure can also be used for MALDI-TOF MS-
based identification of a wide array of clinically relevant mould
species. Usable in the routine clinical laboratory setting, it opens
new avenues for the development of an integrated MALDI-TOF
MS-based solution for the identification of any clinically relevant
microorganisms.
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